Colgate-Palmolive
Market Cap
US$68.0b
Last Updated
2020/10/23 23:56 UTC
Data Sources
Company Financials +
Executive Summary
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. More Details
Snowflake Analysis
Established dividend payer with acceptable track record.
Similar Companies
Share Price & News
How has Colgate-Palmolive's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CL has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-1.2%
CL
-1.9%
US Household Products
-0.8%
US Market
1 Year Return
16.0%
CL
16.5%
US Household Products
18.0%
US Market
Return vs Industry: CL underperformed the US Household Products industry which returned 18% over the past year.
Return vs Market: CL underperformed the US Market which returned 17.8% over the past year.
Shareholder returns
| CL | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.2% | -1.9% | -0.8% |
| 30 Day | 5.6% | 3.4% | 6.8% |
| 90 Day | 6.8% | 9.5% | 8.9% |
| 1 Year | 18.7%16.0% | 19.3%16.5% | 20.7%18.0% |
| 3 Year | 21.2%12.7% | 64.6%51.8% | 41.5%32.1% |
| 5 Year | 34.4%19.6% | 93.4%68.8% | 84.6%63.8% |
Price Volatility Vs. Market
How volatile is Colgate-Palmolive's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Some Shareholders Feeling Restless Over Colgate-Palmolive Company's (NYSE:CL) P/E Ratio6 months ago | Simply Wall St
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 21% Undervalued7 months ago | Simply Wall St
Colgate-Palmolive Company (NYSE:CL) Is Yielding 2.8% - But Is It A Buy?Valuation
Is Colgate-Palmolive undervalued compared to its fair value and its price relative to the market?
26.46x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CL ($79.29) is trading above our estimate of fair value ($78.61)
Significantly Below Fair Value: CL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CL is good value based on its PE Ratio (26.4x) compared to the US Household Products industry average (26.8x).
PE vs Market: CL is poor value based on its PE Ratio (26.4x) compared to the US market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: CL is poor value based on its PEG Ratio (6.2x)
Price to Book Ratio
PB vs Industry: CL is overvalued based on its PB Ratio (253.7x) compared to the US Household Products industry average (7.3x).
Next Steps
Future Growth
How is Colgate-Palmolive forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
4.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CL's forecast earnings growth (4.2% per year) is above the savings rate (2.2%).
Earnings vs Market: CL's earnings (4.2% per year) are forecast to grow slower than the US market (22% per year).
High Growth Earnings: CL's earnings are forecast to grow, but not significantly.
Revenue vs Market: CL's revenue (2.7% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: CL's revenue (2.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CL's Return on Equity is forecast to be very high in 3 years time (261.6%).
Next Steps
Past Performance
How has Colgate-Palmolive performed over the past 5 years?
-0.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CL has high quality earnings.
Growing Profit Margin: CL's current net profit margins (16.1%) are higher than last year (14.8%).
Past Earnings Growth Analysis
Earnings Trend: CL's earnings have declined by 0.5% per year over the past 5 years.
Accelerating Growth: CL's earnings growth over the past year (13%) exceeds its 5-year average (-0.5% per year).
Earnings vs Industry: CL earnings growth over the past year (13%) underperformed the Household Products industry 30.9%.
Return on Equity
High ROE: Whilst CL's Return on Equity (373.22%) is outstanding, this metric is skewed due to their high level of debt.
Next Steps
Financial Health
How is Colgate-Palmolive's financial position?
Financial Position Analysis
Short Term Liabilities: CL's short term assets ($4.2B) do not cover its short term liabilities ($4.6B).
Long Term Liabilities: CL's short term assets ($4.2B) do not cover its long term liabilities ($9.8B).
Debt to Equity History and Analysis
Debt Level: CL's debt to equity ratio (921.3%) is considered high.
Reducing Debt: CL's debt to equity ratio has increased from 887.4% to 921.3% over the past 5 years.
Debt Coverage: CL's debt is well covered by operating cash flow (54.5%).
Interest Coverage: CL's interest payments on its debt are well covered by EBIT (26.7x coverage).
Balance Sheet
Next Steps
Dividend
What is Colgate-Palmolive current dividend yield, its reliability and sustainability?
2.22%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CL's dividend (2.22%) is higher than the bottom 25% of dividend payers in the US market (1.65%).
High Dividend: CL's dividend (2.22%) is low compared to the top 25% of dividend payers in the US market (4.67%).
Stability and Growth of Payments
Stable Dividend: CL's dividends per share have been stable in the past 10 years.
Growing Dividend: CL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (57.7%), CL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CL's dividends in 3 years are forecast to be covered by earnings (59.2% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.6yrs
Average management tenure
CEO
Noel Wallace (56 yo)
1.5yrs
Tenure
US$10,828,665
Compensation
Mr. Noel R. Wallace serves as Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. Mr. Wallace serves as Chairman of Colgate ...
CEO Compensation Analysis
Compensation vs Market: Noel's total compensation ($USD10.83M) is about average for companies of similar size in the US market ($USD11.20M).
Compensation vs Earnings: Noel's compensation has increased by more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 1.5yrs | US$10.83m | 0.028% $ 18.9m | |
| Chief Financial Officer | 2.42yrs | US$3.48m | 0.0055% $ 3.7m | |
| Chief Legal Officer & Secretary | 5.92yrs | US$2.96m | 0.0042% $ 2.8m | |
| Group President of Colgate-Latin America | 1.17yrs | US$2.95m | 0.0053% $ 3.6m | |
| Group President of Global Innovation Group | 1.17yrs | US$3.02m | 0.0016% $ 1.1m | |
| Chief Technology Officer | no data | no data | 0.0065% $ 4.4m | |
| Chief Information Officer | no data | no data | no data | |
| Chief Investor Relations Officer | no data | no data | no data | |
| Vice President of Global Ethics & Compliance | 1.75yrs | no data | no data | |
| VP & Chief Communications Officer | 2.17yrs | no data | no data | |
| Corporate Officer & Chief Human Resources Officer | 0.75yr | no data | 0.0013% $ 897.9k | |
| Chief Supply Chain Officer | no data | no data | no data |
1.6yrs
Average Tenure
60yo
Average Age
Experienced Management: CL's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 1.5yrs | US$10.83m | 0.028% $ 18.9m | |
| Lead Independent Director | no data | US$319.03k | 0.0030% $ 2.0m | |
| Independent Director | 15yrs | US$303.48k | 0.0027% $ 1.8m | |
| Independent Director | 4.58yrs | US$290.48k | 0.0011% $ 748.3k | |
| Independent Director | 1.58yrs | US$236.48k | 0.00041% $ 278.9k | |
| Independent Director | 5.08yrs | US$290.36k | 0.00010% $ 68.0k | |
| Independent Director | 6.33yrs | US$295.36k | 0.0020% $ 1.4m | |
| Independent Director | 0.58yr | no data | 0.00019% $ 129.2k | |
| Independent Director | 5.58yrs | US$295.48k | 0.00055% $ 374.1k | |
| Independent Director | 10.58yrs | US$295.48k | 0.0029% $ 2.0m |
5.1yrs
Average Tenure
61.5yo
Average Age
Experienced Board: CL's board of directors are considered experienced (5.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Colgate-Palmolive Company's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Colgate-Palmolive Company
- Ticker: CL
- Exchange: NYSE
- Founded: 1806
- Industry: Household Products
- Sector: Household
- Market Cap: US$68.026b
- Shares outstanding: 857.40m
- Website: https://www.colgatepalmolive.com
Number of Employees
Location
- Colgate-Palmolive Company
- 300 Park Avenue
- New York
- New York
- 10022
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CL | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Jan 1968 |
| 0P59 | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 1968 |
| CL | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Jan 1968 |
| CPA | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1968 |
| CL * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1968 |
| CPA | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Jan 1968 |
| CPA | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Jan 1968 |
| COLG | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 1968 |
| CL | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 3 REP 1 ORD USD1 | AR | ARS | Nov 2002 | |
| COLG34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REPR 1 COM USD1 | BR | BRL | Sep 2011 |
Biography
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. Th ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/10/23 23:56 |
| End of Day Share Price | 2020/10/23 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.